Mitral Valve Dysfunction in Patients With Annular Calcification: JACC Review Topic of the Week

J Am Coll Cardiol. 2022 Aug 16;80(7):739-751. doi: 10.1016/j.jacc.2022.05.032.

Abstract

Mitral annular calcification (MAC) is a common clinical finding and is associated with adverse clinical outcomes, but the clinical impact of MAC-related mitral valve (MV) dysfunction remains underappreciated. Patients with MAC frequently have stenotic, regurgitant, or mixed valvular disease, and this valvular dysfunction is increasingly recognized to be independently associated with worse prognosis. MAC-related MV dysfunction is a distinct pathophysiologic entity, and importantly much of the diagnostic and therapeutic paradigm from published rheumatic MV disease research cannot be applied in this context, leaving important gaps in our knowledge. This review summarizes the current epidemiology, pathophysiology, diagnosis, and classification of MAC-related MV dysfunction and proposes both an integrative definition and an overarching approach to this important and increasingly recognized clinical condition.

Keywords: MAC-related mitral valve dysfunction; mitral annular calcification; mitral regurgitation; mitral stenosis; transcatheter mitral valve replacement.

Publication types

  • Review
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcinosis* / diagnostic imaging
  • Calcinosis* / epidemiology
  • Heart Valve Diseases* / diagnosis
  • Heart Valve Diseases* / diagnostic imaging
  • Heart Valve Prosthesis Implantation* / adverse effects
  • Humans
  • Mitral Valve / surgery
  • Mitral Valve Insufficiency* / diagnostic imaging
  • Mitral Valve Insufficiency* / epidemiology
  • Prognosis
  • Treatment Outcome